Tango Therapeutics (TNGX) Other Non Operating Income (2020 - 2026)

Tango Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Other Non Operating Income changed 0.47% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 37.33% YoY), while the FY2025 annual figure was $4.1 million, down 46.54% from the prior year.
• Other Non Operating Income was $1.1 million for Q1 2026 at Tango Therapeutics, down from $1.4 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.2 million in Q1 2024 to a low of -$47000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income jumped 2689.36% in 2023, then plunged 63.96% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $967000.0 in 2022, then jumped by 113.13% to $2.1 million in 2023, then retreated by 28.38% to $1.5 million in 2024, then slipped by 6.5% to $1.4 million in 2025, then dropped by 21.81% to $1.1 million in 2026.
• The last three Other Non Operating Income figures came in at $1.1 million (Q1 2026), $1.4 million (Q4 2025), and $705000.0 (Q3 2025), per Business Quant data.